Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Am J Prev Med. 2016 Apr 1;51(4):e107–e115. doi: 10.1016/j.amepre.2016.02.025

Table 2.

Odds of Completing a CRC Screening Episode (During 18 Months) by Race/Ethnicity: PROSPR Cohort 2010–2012

Screened % AORa 95% CI AORb 95% CI
Overall N=1,746,714
Non-Hispanic white 54.4 1.00 (ref) 1.00 (ref)
Non-Hispanic black 50.9 0.93 0.92–0.95 0.89 0.88–0.91
Hispanic 53.9 1.07 1.06–1.08 0.99 0.98–1.00
Asian/Pacific Islander 59.2 1.20 1.18–1.21 1.16 1.15–1.18
American Indian/Alaska Native 47.7 0.84 0.79–0.89 0.76 0.72–0.81
Multiple/other 63.6 1.34 1.30–1.38 1.31 1.28–1.34
Group health N=111,596
Non-Hispanic white 32.1 1.00 (ref) 1.00 (ref)
Non-Hispanic black 30.8 1.02 0.95–1.09 1.01 0.93–1.09
Hispanic 32.5 1.07 0.99–1.15 1.09 1.00–1.20
Asian/Pacific Islander 35.9 1.31 1.25–1.39 1.23 1.16–1.29
American Indian/Alaska Native 24.7 0.77 0.64–0.92 0.72 0.59–0.88
Multiple/Other 29.0 1.06 0.95–1.22 0.94 0.85–1.04
Kaiser Northern N=788,584
Non-Hispanic white 58.2 1.00 (ref) 1.00 (ref)
Non-Hispanic black 53.2 0.90 0.88–0.92 0.86 0.84–0.88
Hispanic 53.7 0.97 0.96–0.99 0.92 0.90–0.93
Asian/Pacific Islander 61.6 1.22 1.20–1.24 1.18 1.16–1.20
American Indian/Alaska Native 50.0 0.83 0.76–0.91 0.75 0.69–0.80
Multiple/other 68.3 1.39 1.34–1.43 1.40 1.36–1.45
Kaiser Southern N=798,250
Non-Hispanic white 55.4 1.00 (ref) 1.00 (ref)
Non-Hispanic black 53.7 0.97 0.95–0.99 0.91 0.89–0.92
Hispanic 55.0 1.10 1.09–1.12 1.02 1.01–1.04
Asian/Pacific Islander 59.3 1.15 1.13–1.17 1.13 1.11–1.15
American Indian/Alaska Native 52.9 0.90 0.83–0.99 0.85 0.77–0.94
Multiple/Other 54.8 1.09 0.93–1.27 1.00 0.87–1.15
Parkland - UT Southwestern N=48,284
Non-Hispanic white 33.7 1.00 (ref) 1.00 (ref)
Non-Hispanic black 37.0 1.06 0.98–1.14 1.12 0.93–1.31
Hispanic 45.7 1.47 1.36–1.58 1.15 0.97–1.34
Asian/Pacific Islander 38.3 1.11 0.95, 1.35 1.16 0.82–1.66
American Indian/Alaska Native 38.5 0.82 0.47–1.28 0.97 0.38–2.18
Multiple/other 27.6 0.60 0.22–1.39 0.47 0.09–1.94
a

Adjusted for age, sex, length of prior enrollment, and study site

b

Adjusted for age, sex, study site, length of prior enrollment, ZIP code median income, type of residence, insurance type, and Charlson co-morbidity score

CRC, colorectal cancer; PROSPR, Population-based Research Optimizing Screening through Personalized Regimens